Lv3
210 积分 2024-02-28 加入
Development of LXR inverse agonists to treat MAFLD, NASH, and other metabolic diseases
28天前
已完结
Treatment of chronic obstructive pulmonary disease: current pipeline and new opportunities
1个月前
已完结
Quantifying the chameleonic properties of macrocycles and other high-molecular-weight drugs
1个月前
已完结
Application of Bioisosteres in the Design and Discovery of FDA-Approved Drugs and Advanced Clinical Candidates
1个月前
已完结
Discovery of BI 7446: A Potent Cyclic Dinucleotide STING Agonist with Broad-Spectrum Variant Activity for the Treatment of Cancer
1个月前
已完结
An Insight into the cGAS-STING Pathway Modulation by Metal Complexes to Initiate Immunogenic Cell Death in Cancer
1个月前
已完结
Overcoming hERG Cardiotoxicity in Psammaplysene D via Rational Design to Discover a Safe Antifibrotic Lead
1个月前
已完结
Ensifentrine: First Approval
2个月前
已完结
Asymmetric Total Synthesis of the Rearranged Steroid Phomarol Enabled by a Biomimetic SN2′ Cyclization
2个月前
已完结
Pharmacology and Therapeutics of Asthma and COPD
2个月前
已完结
皖公网安备34019202002308
